13871-9 |
Thyrotropin^2H post dose TRH IV |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Thyrotropin [Mass/volume] in Serum or Plasma --2 hours post dose TRH IV |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
13871-9 |
|
|
|
|
Observation |
|
|
|
0 |
TSH 2h p TRH IV SerPl-mCnc |
|
|
|
Y |
|
120 min; 120 minutes; 120min; 2 hours; 2h p TRH; 2h p TRH IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p dose; p TRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH |
2.42 |
1.0k |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
13872-7 |
11-Deoxycortisol |
MRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
11-Deoxycortisol [Mass/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
ug/24 H |
|
|
|
|
|
|
CHEM |
|
13872-7 |
|
|
|
|
Both |
|
|
|
0 |
11DC 24h Ur-mRate |
|
|
|
Y |
|
1 day; 11DC; 24 hours; 24HR; Chemistry; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Mass rate; Metopirone; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
ug/(24.h) |
|
|
|
0 |
13873-5 |
Albumin.glycated/Albumin.total |
MFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Albumin.glycated/Albumin.total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
13873-5 |
|
|
|
|
Observation |
|
|
|
0 |
Albumin Glycated MFr SerPl |
|
|
|
Y |
|
Alb; Albumin Glycated; Chemistry; Glycos; Glycosylated; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
13874-3 |
Alkaline phosphatase.liver 1 |
CCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
13874-3 |
|
|
|
|
Observation |
|
|
|
0 |
ALP Liver 1 SerPl-cCnc |
|
|
|
Y |
|
Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; ALP Liver; ALP Liver 1; ALP-1; AP; Catalytic Concentration; Chemistry; Hepatology; i; Liver; Phos; Phosphtase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
13875-0 |
Alkaline phosphatase.liver 2 |
CCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
13875-0 |
|
|
|
|
Observation |
|
|
|
0 |
ALP Liver 2 SerPl-cCnc |
|
|
|
Y |
|
Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; ALP Liver; ALP Liver 2; ALP-1; AP; Catalytic Concentration; Chemistry; Hepatology; II; Liver; Phos; Phosphtase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
13876-8 |
Beta-2 transferrin |
PrThr |
Body fld |
Pt |
Ord |
|
|
ACTIVE |
Beta-2 transferrin [Presence] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
13876-8 |
|
|
|
|
Both |
|
|
|
0 |
B2 Transferrin Fld Ql |
|
|
|
|
|
B; B/F; B2 Transferrin; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; II; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Siderophilin; t fraction; Tf; Trf; TRFRN |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
13877-6 |
Bilirubin |
PrThr |
Amnio fld |
Pt |
Ord |
|
|
ACTIVE |
Bilirubin.total [Presence] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
|
1+; 2+, etc. |
|
|
|
|
|
CHEM |
|
13877-6 |
|
|
|
|
Both |
|
|
|
0 |
Bilirub Amn Ql |
|
|
|
|
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Bili; Bilirubins; Billirubin; Chemistry; Gyn; Gynecology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; TBIL |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
13878-4 |
Collagen type 1 Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Collagen type 1 IgG Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
13878-4 |
|
|
|
|
Both |
|
|
|
0 |
Collagen1 IgG Ser-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CIAb; Collagen type I; Collagen1; i; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR |
2.69 |
1.0k |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
13879-2 |
Collagen type 2 Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Collagen type 2 IgG Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
13879-2 |
|
|
|
|
Both |
|
|
|
0 |
Collagen2 IgG Ser-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CIIAb; Collagen type II; Collagen2; II; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
1388-8 |
Catecholamines.free fractionated^pre 300 ug cloNIDine PO |
MCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Catecholamines Free fractionated [Mass/volume] in Plasma --pre 300 ug cloNIDine PO |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
CHAL |
|
1388-8 |
|
|
|
|
Observation |
|
|
|
0 |
FCA Fract pre 300 ug CLN PO Plas-mCnc |
|
|
|
Y |
|
Before; Catapres; Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; CHEMISTRY.CHALLENGE TESTING; Epinephrine+norepinephrine+dopamine; FCA; FCA Fract; FR; Frac; Fract; Fraction; Level; Mass concentration; mcg; Non-protein bound; Pl; Plasma; Plsm; Point in time; pre 300 ug CLN PO; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
13880-0 |
Collagen type 4 Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Collagen type 4 IgG Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
13880-0 |
|
|
|
|
Both |
|
|
|
0 |
Collagen4 IgG Ser-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CIVAb; Collagen type IV; Collagen4; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR |
2.69 |
1.0k |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
13881-8 |
Deoxypyridinoline.free/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Deoxypyridinoline Free/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
13881-8 |
|
|
|
|
Both |
|
|
|
0 |
DPD Free/Creat Ur-sRto |
|
|
|
Y |
|
Chemistry; CR; Crea; Creat; DPD; DPD Free; Dpyr; FR; Free lysly-pyridinoline; Lysylpyridinoline; Non-protein bound; Point in time; Pyradinium collagen crosslinks; Pyrilinks D; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
nmol/mmol{creat} |
|
|
|
0 |
13882-6 |
Androstanolone.free/Androstanolone.total |
MFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Androstanolone Free/Androstanolone.total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
13882-6 |
|
|
|
|
Observation |
|
|
|
0 |
Androstanolone Free MFr SerPl |
|
|
|
Y |
|
Androstanolone Free; Chemistry; DHT; Dihydrotestosterone; FR; Mass fraction; Non-protein bound; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
13883-4 |
Estradiol.bioavailable/Estradiol.total |
MFr |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Estradiol (E2).bioavailable/Estradiol (E2).total in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
13883-4 |
|
|
|
|
Observation |
|
|
|
0 |
Estradiol Bioavail MFr SerPl |
|
|
|
Y |
|
17-beta estradiol; Chemistry; E2; Estradiol Bioavail; Gyn; Gynecology; Mass Fraction; OB; ObGyn; Obstetrics; Oestradiol; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
13884-2 |
Estradiol.bioavailable |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Estradiol (E2).bioavailable [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHEM |
|
13884-2 |
|
|
|
|
Both |
|
|
|
0 |
Estradiol Bioavail SerPl-mCnc |
|
|
|
Y |
|
17-beta estradiol; Chemistry; E2; Estradiol Bioavail; Gyn; Gynecology; Level; Mass concentration; OB; ObGyn; Obstetrics; Oestradiol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
13885-9 |
Estrogen/Creatinine |
MCrto |
Urine |
24H |
Qn |
|
|
DEPRECATED |
Deprecated Estrogen/Creatinine [Mass ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
ug/g creatinine |
|
|
|
|
|
|
CHEM |
|
13885-9 |
|
|
|
|
|
|
|
|
0 |
Deprecated Estrogen/creat 24H Ur-mRto |
|
|
|
|
|
1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Est; Estr; Estroge; Estrogens; Estrone+estradiol; Estrone+estradiol+estriol; QNT; Quan; Quant; Quantitative; UA; UCr; UR; Urn |
2.7 |
1.0k |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
13886-7 |
Lactate dehydrogenase 1/Lactate dehydrogenase.total |
CFr |
Urine |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Lactate dehydrogenase 1/Lactate dehydrogenase.total in Urine by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
13886-7 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
LDH1 CFr Ur Elph |
|
|
|
Y |
|
2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Fraction; Chemistry; Dehydrog; Dehyrdogenase; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; i; L.D.H; Lact; Lactate dehydrogenase.fraction 1; Lactic acid; Lactic acid dehydrogenase; LD; LD1; LD-1; LDH; LDH isoenzyme 1; LDH1; L-lactate; L-lactate dehydrogenase; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; Tumor marker; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
13887-5 |
Lactate dehydrogenase 2/Lactate dehydrogenase.total |
CFr |
Urine |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Lactate dehydrogenase 2/Lactate dehydrogenase.total in Urine by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
13887-5 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
LDH2 CFr Ur Elph |
|
|
|
Y |
|
2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Fraction; Chemistry; Dehydrog; Dehyrdogenase; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; II; L.D.H; Lact; Lactate dehydrogenase.fraction 2; Lactic acid; Lactic acid dehydrogenase; LD; LD2; LD-2; LDH; LDH isoenzyme 2; LDH2; L-lactate; L-lactate dehydrogenase; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; Tumor marker; UA; UR; Urn |
2.7 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
13888-3 |
Lactate dehydrogenase 3/Lactate dehydrogenase.total |
CFr |
Urine |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Lactate dehydrogenase 3/Lactate dehydrogenase.total in Urine by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
13888-3 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
LDH3 CFr Ur Elph |
|
|
|
Y |
|
2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Fraction; Chemistry; Dehydrog; Dehyrdogenase; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; III; L.D.H; Lact; Lactate dehydrogenase.fraction 3; Lactic acid; Lactic acid dehydrogenase; LD; LD3; LDH; LDH isoenzyme 3; LDH3; L-lactate; L-lactate dehydrogenase; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; Tumor marker; UA; UR; Urn |
2.7 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
13889-1 |
Lactate dehydrogenase 4/Lactate dehydrogenase.total |
CFr |
Urine |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Lactate dehydrogenase 4/Lactate dehydrogenase.total in Urine by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
13889-1 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
LDH4 CFr Ur Elph |
|
|
|
Y |
|
2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Fraction; Chemistry; Dehydrog; Dehyrdogenase; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; L.D.H; Lact; Lactate dehydrogenase.fraction 4; Lactic acid; Lactic acid dehydrogenase; LD; LD4; LDH; LDH isoenzyme 4; LDH4; L-lactate; L-lactate dehydrogenase; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; Tumor marker; UA; UR; Urn |
2.7 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
1389-6 |
Cortisol.free^24H post 40 ug corticotropin IM BID 3 day |
MCnc |
Urine |
24H |
Qn |
|
|
ACTIVE |
Cortisol Free [Mass/volume] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
1389-6 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis F 1D p 40 ug ACTH IM 24h Ur-mCnc |
|
|
|
Y |
|
1 day; 17-Hydroxycorticosterone; 1D p 40 ug ACTH IM; 24 hours; 24HR; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cortis F; Cortrosyn; F; FR; hydrocortisone; III; Level; Mass concentration; mcg; Non-protein bound; PST; QNT; Quan; Quant; Quantitative; Rc206; Tumor marker; twice a day; UA; UR; Urn |
2.34 |
1 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
13890-9 |
Lactate dehydrogenase 5/Lactate dehydrogenase.total |
CFr |
Urine |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Lactate dehydrogenase 5/Lactate dehydrogenase.total in Urine by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
13890-9 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
LDH5 CFr Ur Elph |
|
|
|
Y |
|
2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Fraction; Chemistry; Dehydrog; Dehyrdogenase; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; L.D.H; Lact; Lactate dehydrogenase.fraction 5; Lactic acid; Lactic acid dehydrogenase; LD; LD5; LDH; LDH isoenzyme 5; LDH5; L-lactate; L-lactate dehydrogenase; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; Tumor marker; UA; UR; Urn |
2.7 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
|
0 |
13891-7 |
Motilin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Motilin [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHEM |
|
13891-7 |
|
|
|
|
Both |
|
|
|
0 |
Motilin SerPl-mCnc |
|
|
|
Y |
|
Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
1.0k |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
13892-5 |
Nitrosonaphthol |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Nitrosonaphthol [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
13892-5 |
|
|
|
|
Both |
|
|
|
0 |
Nitrosonaphthol Ur Ql |
|
|
|
|
|
Chemistry; NNT; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
13893-3 |
Phenylalanine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Phenylalanine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
13893-3 |
|
|
|
|
Observation |
|
|
|
0 |
Phe Ur Ql |
|
|
|
|
|
Chemistry; Ordinal; Phe; Point in time; PPA; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |